|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Moody's Investors Service ("Moody's") affirmed Cvent Inc.'s ("Cvent") Corporate Family rating ("CFR") at B3, Probability of Default rating ("PDR") at B3-PD and senior secured first lien revolver and term loan at B3. The rating outlook was revised to stable from positive. On Tuesday, Cvent announced it had acquired Social Tables, Inc. ("Social Tables") in a debt-financed transaction funded in part by a $53 million increase in its senior secured 1st lien term loan, bringing the total outstanding amount to approximately $750 million.
The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday: ** Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion. ** Pebblebrook Hotel Trust has sweetened its $3 billion-plus offer to buy U.S. peer LaSalle Hotel Properties after the owner of high-end locations including 'W' Los Angeles saw an initial bid rebuffed last month.